Vaccine billionaire, who set up Serum Institute of India 50 years ago, gained on rising revenue and profit at the privately owned firm, which son, Adar, helps him run. Serum reported a record profit of $360 million on revenue of $695 million for the year ended March 2016. Poonawalla is investing $150 million in a factory to make a range of new vaccines, including for dengue, pneumonia and diarrhea. Adar featured among FORBES ASIA's Heroes of Philanthropy this year for donating $15 million to cleaning up Pune, where the family resides.